Drug Safety Update February 2009
admin February 4th, 2009
Drug Safety Update by the MHRA includes this month:
- Tibolone (Livial): increased risk of breast cancer recurrence
- Non-steroidal anti-inflammatory drugs: cardiovascular risk
- Toremifene (Fareston): risk of QT prolongation
- Methylphenidate: new guidance for use in treatment of ADHD
- Correction: Temsirolimus—severe hypersensitivity reactions during infusion
- MHRA
- Comments Off